Although we found that DFMO by itself only has a minor effect on the accumulation of DNA damage, DFMO coupled with PARP inhibition can overcome the DNA repair capacity of HR-competent ovarian tumor cells. The gene discussed is PARP1; the disease is ovarian neoplasm.